(redirected from G-CSF)
Also found in: Dictionary, Medical, Legal, Financial, Acronyms, Encyclopedia, Wikipedia.
Graphic Thesaurus  🔍
Display ON
Animation ON
  • all
  • noun
  • verb

Synonyms for factor

Synonyms for factor

one of the individual entities contributing to a whole

one of the conditions or facts attending an event and having some bearing on it

Synonyms for factor

one of two or more integers that can be exactly divided into another integer

any of the numbers (or symbols) that form a product when multiplied together

an independent variable in statistics

be a contributing factor

consider as relevant when making a decision

References in periodicals archive ?
As part of its coverage, the report provides the following: Scientific Differences of Pharmaceuticals and Biopharmaceuticals Market Share of Biosimilar Sales in Comparison to Brand Sales Marketed Biologics with Expired Patents Marketed Biologics with Active Patents Cost Savings From Biosimilar Use World Biosimilar Market Potential by Region 2010-2017 World Biosimilar Market Potential by Biological Class 2010-2017 ( EPO, G-CSF, HGH, Insulin, Interferon Alpha, Monoclonal Antibodies, Other) Biosimilars Pipeline by Company and Product Type
Dr Andrew Cuthbertson, Director of R&D at CSL said, "The G-CSF inflammatory disease project is an excellent example of the strength of Australian medical research.
The competition is fierce in China with about 20 G-CSF products already in the market.
With genotype 2 and genotype 3 patients, we would need to treat 13 with erythropoietin or 54 with G-CSF to obtain 1 additional SVR, when compared with dosage reductions of ribavirin or pegylated interferon, respectively The estimated cost for each SVR is $125,000-$500,000.
G-CSF levels were significantly higher 1236 hours before delivery among those with funisitis (116.
At the Sloan-Kettering Cancer Center in New York City, 18 patients with a cancer called transitional-cell carcinoma were given G-CSF after a standard chemotherapy regimen that depletes cell numbers.
To order this report: The World Market for Biosimlars (EPO, G-CSF, HGH, Insulin, Interferon Alpha, Monoclonal Antibodies, Other), 4th Edition utm_campaign=Biopharmaceutical
In two randomized trials - one in patients with NHL, the other in patients with MM - Mozobil combined with G-CSF increased the number of stem cells available for collection and transplantation compared with G-CSF alone.
Kwizda Pharma of Austria had been working with IBPL to develop G-CSF for the European market for some time.
Kirin has strong presence in hematology field through its product pipeline including CliniMACS, Busulfex and second-generation of G-CSF in Japan.
According to G-CSF Biosimilars Market Forecast to 2015, the overall market is presently dominated by first-generation biosimilars, and it is likely that their second-generation will grow phenomenally in the future.
A Phase I, Randomised, Open Label Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Subcutaneous Doses of ATL1102 Alone and in Combination with G-CSF in Healthy Volunteers